Cargando…

Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model

The murine leukemia virus-based semi-retroviral replicating vectors (MuLV-based sRRV) had been developed to improve safety and transgene capacity for cancer gene therapy. However, despite the apparent advantages of the sRRV, improvements in the in vivo transduction efficiency are still required to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Moonkyung, Song, Ayoung, Kim, Jiyoung, Kang, Se Hun, Lee, Sang-Jin, Kim, Yeon-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813426/ https://www.ncbi.nlm.nih.gov/pubmed/36195571 http://dx.doi.org/10.5483/BMBRep.2022.55.12.136

Ejemplares similares

Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models
por: Lee, Mijeong, et al.
Publicado: (2019)

Dual-vector prodrug activator gene therapy using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018)

The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
por: Anson, Donald S
Publicado: (2004)

Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
por: Hiraoka, Kei, et al.
Publicado: (2017)

Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors
por: Bii, Victor M., et al.
Publicado: (2016)

In vitro inhibition of CSFV replication by retroviral vector-mediated RNA interference
por: Li, Jiangnan, et al.
Publicado: (2010)

Infection with retroviral vectors leads to perturbed DNA replication increasing vector integrations into fragile sites
por: Bester, Assaf C., et al.
Publicado: (2013)

Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors
por: Paar, Matthias, et al.
Publicado: (2009)

Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells
por: Grunwald, Vivien, et al.
Publicado: (2023)

Intrahippocampal injection of a lentiviral vector expressing neurogranin enhances cognitive function in 5XFAD mice
por: Jeon, Seong Gak, et al.
Publicado: (2018)

Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors (RRV) in a rodent brain tumor model
por: Yin, Dali, et al.
Publicado: (2013)

Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro
por: Lin, Amy H., et al.
Publicado: (2017)

Elevated level of PLRG1 is critical for the proliferation and maintenance of genome stability of tumor cells
por: Choi, Hyunji, et al.
Publicado: (2023)

Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018)

Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model
por: Fujino, Hiroaki, et al.
Publicado: (2023)

Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation
por: Lee, Se Yeong, et al.
Publicado: (2022)

Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer
por: Kushiya, Hiroki, et al.
Publicado: (2022)

A new generation of pPRIG-based retroviral vectors
por: Albagli-Curiel, Olivier, et al.
Publicado: (2007)

Restriction of Retroviral Replication by Tetherin/BST-2
por: Hammonds, Jason, et al.
Publicado: (2012)

Enhanced gene expression from retroviral vectors
por: Blø, Magnus, et al.
Publicado: (2008)

Improved Coinfection with Amphotropic Pseudotyped Retroviral Vectors
por: Wu, Yuehong, et al.
Publicado: (2009)

Retroviral Vector Biosafety: Lessons from Sheep
por: Van den Broeke, Anne, et al.
Publicado: (2003)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
por: Dufait, Inès, et al.
Publicado: (2012)

Retroviral Vectors for Analysis of Viral Mutagenesis and Recombination
por: Rawson, Jonathan M.O., et al.
Publicado: (2014)

Postexit Surface Engineering of Retroviral/Lentiviral Vectors
por: Metzner, Christoph, et al.
Publicado: (2013)

Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping
por: Kim, Soo-hyun, et al.
Publicado: (2017)

Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids
por: Burnett, Ryan, et al.
Publicado: (2014)

Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
por: Caffery, Breanne, et al.
Publicado: (2019)

Development of a new bicistronic retroviral vector with strong IRES activity
por: Martin, Patrick, et al.
Publicado: (2006)

Characterisation of FEZ1-mediated inhibition of retroviral replication
por: Brown, Craig, et al.
Publicado: (2009)

Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery
por: Bobis-Wozowicz, Sylwia, et al.
Publicado: (2014)

Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies
por: Mohanlal, Ramon, et al.
Publicado: (2016)

Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model
por: Chen, Shih-Han, et al.
Publicado: (2020)

Retroviral Gene Vectors Show Clear Target Preferences
Publicado: (2004)

Retroviral Vectors: Post Entry Events and Genomic Alterations
por: Nowrouzi, Ali, et al.
Publicado: (2011)

High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages
por: Wu, Chengxiang, et al.
Publicado: (2010)

Radio-sensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector
por: Takahashi, Masamichi, et al.
Publicado: (2014)

A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models
por: Yagiz, Kader, et al.
Publicado: (2017)

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models
por: Mitchell, Leah A., et al.
Publicado: (2019)

Oncolytic Foamy Virus: Generation and Properties of a Nonpathogenic Replicating Retroviral Vector System That Targets Chronically Proliferating Cancer Cells
por: Budzik, Karol M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fm1c0935ft03s9cihrk0cgubj7